Nova Eye Medical Ltd
ASX:EYE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cyberjaya Education Group Bhd
KLSE:CYBERE
|
MY |
Nova Eye Medical Ltd
Total Receivables
Nova Eye Medical Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nova Eye Medical Ltd
ASX:EYE
|
Total Receivables
AU$4.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Somnomed Ltd
ASX:SOM
|
Total Receivables
AU$18.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Cochlear Ltd
ASX:COH
|
Total Receivables
AU$564.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Total Receivables
AU$3.2m
|
CAGR 3-Years
47%
|
CAGR 5-Years
60%
|
CAGR 10-Years
21%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Total Receivables
AU$15.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Total Receivables
AU$5.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nova Eye Medical Ltd
Glance View
Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. The company is headquartered in Adelaide, South Australia and currently employs 130 full-time employees. The firm is focused on developing, manufacturing and selling a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), which is a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patients' reliance on anti-glaucoma medications for mild-moderate glaucoma. Its Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma. The firm's 2RT is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD).
See Also
What is Nova Eye Medical Ltd's Total Receivables?
Total Receivables
4.1m
AUD
Based on the financial report for Dec 31, 2025, Nova Eye Medical Ltd's Total Receivables amounts to 4.1m AUD.
What is Nova Eye Medical Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
-1%
Over the last year, the Total Receivables growth was 33%. The average annual Total Receivables growth rates for Nova Eye Medical Ltd have been 3% over the past three years , -1% over the past five years .
